UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The G8 screening tool detects relevant geriatric impairments and predicts survival in elderly patients with a haematological malignancy

Annals of hematology, 2014-06, Vol.93 (6), p.1031-1040

2014

Volltextzugriff (PDF)

Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines

Annals of oncology, 2018-10, Vol.29 (Supplement_4), p.iv96-iv110

2018

Volltextzugriff (PDF)

The relevance of a geriatric assessment for elderly patients with a haematological malignancy – A systematic review

Leukemia research, 2014-03, Vol.38 (3), p.275-283

2014

Volltextzugriff (PDF)

Approach to therapy of diffuse large B-cell lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentary

Annals of oncology, 2015-06, Vol.26 (6), p.1058-1068

2015

Volltextzugriff (PDF)

Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials

Blood, 2019-03, Vol.133 (10), p.1020-1030

2019

Volltextzugriff (PDF)

Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an international Society of Geriatric Oncology (SIOG) Task Force

Annals of oncology, 2017-02, Vol.28 (2), p.218-227

2017

Volltextzugriff (PDF)

Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study Group

Annals of oncology, 2010-01, Vol.21 (1), p.114-119

2010

Volltextzugriff (PDF)

A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ⩽30% blasts

Leukemia, 2017-12, Vol.31 (12), p.2799-2806

2017

Volltextzugriff (PDF)

Fatigue at baseline is associated with geriatric impairments and represents an adverse prognostic factor in older patients with a hematological malignancy

Annals of hematology, 2018-11, Vol.97 (11), p.2235-2243

2018

Volltextzugriff (PDF)

Clinical judgement and geriatric assessment for predicting prognosis and chemotherapy completion in older patients with a hematological malignancy

Leukemia & lymphoma, 2016-11, Vol.57 (11), p.2560-2567

2016

Volltextzugriff (PDF)

S168: ERYTHROPOIETIN STIMULATION AGENTS SIGNIFICANTLY IMPROVES OUTCOME IN LOWER RISK MDS

HemaSphere, 2022-06, Vol.6, p.69-70

2022

Volltextzugriff (PDF)

The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification

Leukemia, 2024-02, Vol.38 (2), p.442-445

2024

Volltextzugriff (PDF)

Onkologische Chirurgie 4.0

Der Onkologe, 2018-05, Vol.24 (5), p.400-405

2018

Volltextzugriff (PDF)

Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines

Annals of oncology, 2018-10, Vol.29 (Supplement_4), p.iv271-iv271

2018

Volltextzugriff (PDF)

Relevance of age and comorbidities in risk scoring and decision making in MDS in the elderly

Journal of geriatric oncology, 2013-10, Vol.4, p.S12-S13

Stauder, R

2013

Volltextzugriff (PDF)

Azacitidine is removed effectively by hemodialysis

Leukemia & lymphoma, 2021-02, Vol.62 (3), p.743-745

2021

Volltextzugriff (PDF)

On-going clinical trials for elderly patients with a hematological malignancy: are we addressing the right end points?

Annals of oncology, 2014-03, Vol.25 (3), p.675-681

2014

Volltextzugriff (PDF)

Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): A multicenter study

Leukemia, 2012-06, Vol.26 (6), p.1286-1292

2012

Volltextzugriff (PDF)

F14 MDS: a challenge, especially in elderly patients

Critical reviews in oncology/hematology, 2009, Vol.72 (1), p.S10-S11

Stauder, R

2009

Volltextzugriff (PDF)

Hematological malignancies in the elderly

Journal of geriatric oncology, 2012-10, Vol.3, p.S24-S24

Stauder, R

2012

Volltextzugriff (PDF)

Erythropoiesis‐stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower‐risk myelodysplastic syndrome

Journal of internal medicine, 2017-03, Vol.281 (3), p.284-299

2017

Volltextzugriff (PDF)

Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromes

Annals of oncology, 2014-02, Vol.25 (2), p.447-454

2014

Volltextzugriff (PDF)

Corrections to “Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines”

Annals of oncology, 2018-10, Vol.29, p.iv271-iv271

2018

Volltextzugriff (PDF)

1 – 25 von 345

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(328)
Mit Volltextzugriff
(296)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(150)
Life Sciences & Biomedicine
(143)
Humans
(128)
Female
(75)
Hematology
(73)
Oncology
(72)
Aged
(71)
Male
(67)
Middle Aged
(66)
Hematology, Oncology And Palliative Medicine
(60)
Adult
(52)
Aged, 80 And Over
(49)
Medicin Och Hälsovetenskap
(42)
Prognosis
(38)
Biological And Medical Sciences
(33)
Medical Sciences
(30)
Myelodysplastic Syndromes
(28)
Treatment Outcome
(23)
Hematologic And Hematopoietic Diseases
(20)
Patients
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The G8 screening tool detects relevant geriatric impairments and predicts survival in elderly patients with a haematological malignancy

Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines

The relevance of a geriatric assessment for elderly patients with a haematological malignancy – A systematic review

Approach to therapy of diffuse large B-cell lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentary

Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials

ESMO Consensus Conference on malignant lymphoma: general perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma

Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an international Society of Geriatric Oncology (SIOG) Task Force

Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study Group

A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ⩽30% blasts

Fatigue at baseline is associated with geriatric impairments and represents an adverse prognostic factor in older patients with a hematological malignancy

Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM)

Clinical judgement and geriatric assessment for predicting prognosis and chemotherapy completion in older patients with a hematological malignancy

S168: ERYTHROPOIETIN STIMULATION AGENTS SIGNIFICANTLY IMPROVES OUTCOME IN LOWER RISK MDS

The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification

Onkologische Chirurgie 4.0

Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines

Relevance of age and comorbidities in risk scoring and decision making in MDS in the elderly

Azacitidine is removed effectively by hemodialysis

On-going clinical trials for elderly patients with a hematological malignancy: are we addressing the right end points?

Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): A multicenter study

F14 MDS: a challenge, especially in elderly patients

Hematological malignancies in the elderly

Erythropoiesis‐stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower‐risk myelodysplastic syndrome

Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromes

Corrections to “Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines”

Suchergebnisse filtern